We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Urology

Journal Scan / Research · April 24, 2021

Retroperitoneal Lymph Node Dissection in Nonseminoma Patients With Postchemotherapy Residual Tumor

European Urology Oncology

 

Additional Info

European Urology Oncology
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients With Postchemotherapy Residual Tumour? Results From RETROP, a Population-Based Mapping Study by the Swedish Norwegian Testicular Cancer Group
Eur Urol Oncol 2021 Mar 06;[EPub Ahead of Print], A Gerdtsson, A Thor, A Grenabo Bergdahl, B Almås, U Håkansson, M Törnblom, HFS Negaard, I Glimelius, D Halvorsen, Á Karlsdóttir, H Sagstuen Haugnes, K Engen Andreassen, S Melsen Larsen, G Holmberg, R Wahlqvist, T Tandstad, G Cohn-Cedermark, O Ståhl, A Kjellman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading